Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 14, Pages 4843
Publisher
MDPI AG
Online
2020-07-09
DOI
10.3390/ijms21144843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- Sensor Sensibility—HIV-1 and the Innate Immune Response
- (2020) Xin Yin et al. Cells
- Recent Progress on the Versatility of Virus-Like Particles
- (2020) Ciying Qian et al. Vaccines
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma
- (2019) Kyle T. Siebenthall et al. EBioMedicine
- Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice
- (2019) Lasse Neukirch et al. Oncotarget
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- GS-05-MHC-II invariant chain adjuvanted chimpanzee adenoviral and MVA hepatitis C vaccines elicit unprecedented levels of anti-viral T-cell immune responses in humans
- (2019) Ilaria Esposito et al. JOURNAL OF HEPATOLOGY
- Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
- (2019) Melanie Schwerdtfeger et al. Journal of Translational Medicine
- Endogenous retrovirus-encoded Syncytin-2 contributes to exosome-mediated immunosuppression of T cells
- (2019) Adjimon G Lokossou et al. BIOLOGY OF REPRODUCTION
- Extracellular Vesicles Released by Colorectal Cancer Cell Lines Modulate Innate Immune Response in Zebrafish Model: The Possible Role of Human Endogenous Retroviruses
- (2019) Luca Ferrari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
- (2019) Reem Saleh et al. SEMINARS IN CANCER BIOLOGY
- Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
- (2019) Anna Morena D’Alise et al. Nature Communications
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- Evaluating the expression level of HERV-K env, np9, rec and gag in breast tissue
- (2019) Shaian Tavakolian et al. Infectious Agents and Cancer
- The potential of adenoviral vaccine vectors with altered antigen presentation capabilities
- (2019) Lasse Neukirch et al. Expert Review of Vaccines
- Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer
- (2018) Mokhtar Zare et al. MICROBIAL PATHOGENESIS
- Elevated HERV-K Expression in Soft Tissue Sarcoma Is Associated with Worsened Relapse-Free Survival
- (2018) Maria Giebler et al. Frontiers in Microbiology
- Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses
- (2018) Benedict R. Halbroth et al. Scientific Reports
- Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+T Cells
- (2017) Bo Xiang et al. JOURNAL OF IMMUNOLOGY
- Tumour virus vaccines: hepatitis B virus and human papillomavirus
- (2017) Margaret Stanley PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- HEMO, an ancestral endogenous retroviral envelope protein shed in the blood of pregnant women and expressed in pluripotent stem cells and tumors
- (2017) Odile Heidmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA hypomethylation and aberrant expression of the human endogenous retrovirus ERVWE1/syncytin-1 in seminomas
- (2017) Martina Benešová et al. Retrovirology
- Highly sensitive and multiplexed quantification of mRNA splice variants by the direct ligation of DNA probes at the exon junction and universal PCR amplification
- (2017) Honghong Wang et al. Chemical Science
- A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion
- (2017) Cécile Lemaître et al. PLoS Pathogens
- Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype
- (2017) K. Brennan et al. EBioMedicine
- Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype
- (2017) Gary L. Johanning et al. Scientific Reports
- Viral vectors as vaccine platforms: from immunogenicity to impact
- (2016) Katie J Ewer et al. CURRENT OPINION IN IMMUNOLOGY
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice
- (2016) Anne-Marie Carola Andersson et al. Journal of Translational Medicine
- Long Terminal Repeats: From Parasitic Elements to Building Blocks of the Transcriptional Regulatory Repertoire
- (2016) Peter J. Thompson et al. MOLECULAR CELL
- Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks
- (2016) Agata Michna et al. Radiation Oncology
- An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression
- (2016) Emeline Ragonnaud et al. VACCINE
- Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells
- (2016) Fuling Zhou et al. Oncotarget
- Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma
- (2015) J. Krishnamurthy et al. CLINICAL CANCER RESEARCH
- Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas
- (2015) Paolo Fava et al. DERMATOLOGY
- Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation
- (2015) Jonas Hummel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The KRAB zinc finger protein ZFP809 is required to initiate epigenetic silencing of endogenous retroviruses
- (2015) Gernot Wolf et al. GENES & DEVELOPMENT
- Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K–Related Sequences
- (2015) Rafael Contreras-Galindo et al. JOURNAL OF VIROLOGY
- Human endogenous retrovirus HERV-K(HML-2) activity in prostate cancer is dominated by a few loci
- (2015) Wolfgang Goering et al. PROSTATE
- Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras
- (2015) Fuling Zhou et al. OncoImmunology
- Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets.
- (2015) Pamela L. Strissel et al. Oncotarget
- Induction of Immunoregulatory CD271+ Cells by Metastatic Tumor Cells That Express Human Endogenous Retrovirus H
- (2014) C. Kudo-Saito et al. CANCER RESEARCH
- Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers
- (2014) Tiffany A. Wallace et al. CARCINOGENESIS
- Cytotoxicity of Human Endogenous Retrovirus K-Specific T Cells toward Autologous Ovarian Cancer Cells
- (2014) K. Rycaj et al. CLINICAL CANCER RESEARCH
- MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines
- (2014) P. J. Holst et al. JOURNAL OF IMMUNOLOGY
- Co-Expression of Tumor Antigen and Interleukin-2 From an Adenoviral Vector Augments the Efficiency of Therapeutic Tumor Vaccination
- (2014) Benjamin Anderschou Holbech Jensen et al. MOLECULAR THERAPY
- Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system
- (2014) Benjamin Kraus et al. Virology Journal
- Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden
- (2014) Francesca Scrimieri et al. OncoImmunology
- Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein
- (2013) B. S. Reis et al. CLINICAL CANCER RESEARCH
- Transcriptional Profiling of Human Endogenous Retrovirus Group HERV-K(HML-2) Loci in Melanoma
- (2013) Katja Schmitt et al. Genome Biology and Evolution
- The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells
- (2013) T Chen et al. LEUKEMIA
- Mutations in 3′-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb
- (2013) H Yu et al. ONCOGENE
- Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System
- (2013) Benjamin Kraus et al. PLoS One
- The Transmembrane Protein of the Human Endogenous Retrovirus - K (HERV-K) Modulates Cytokine Release and Gene Expression
- (2013) Vladimir A. Morozov et al. PLoS One
- Expression of Human Endogenous Retrovirus-W Including Syncytin-1 in Cutaneous T-Cell Lymphoma
- (2013) Pilvi Maliniemi et al. PLoS One
- Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines
- (2013) Lorenzo Agoni et al. Frontiers in Oncology
- The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope
- (2012) M. S. de Souza et al. JOURNAL OF IMMUNOLOGY
- Antigen Incorporated In Virus-like Particles Is Delivered to Specific Dendritic Cell Subsets That Induce An Effective Antitumor Immune Response In Vivo
- (2012) Kunyu Li et al. JOURNAL OF IMMUNOTHERAPY
- Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors
- (2012) Feng Wang-Johanning et al. JNCI-Journal of the National Cancer Institute
- Expression Patterns of Non-Coding Spliced Transcripts from Human Endogenous Retrovirus HERV-H Elements in Colon Cancer
- (2012) Qiaoyi Liang et al. PLoS One
- HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma
- (2012) Darko Gosenca et al. PLoS One
- Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1
- (2012) Vladimir A Morozov et al. Retrovirology
- High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses
- (2011) Matthias W. Kron et al. JOURNAL OF GENE MEDICINE
- Chimeric Trop2 Virus-like Particles
- (2011) Rafael Cubas et al. JOURNAL OF IMMUNOTHERAPY
- Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses
- (2011) Ravi P Subramanian et al. Retrovirology
- Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response
- (2010) R. A. SCHEEREN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- HERV-K Hypomethylation in Ovarian Clear Cell Carcinoma Is Associated With a Poor Prognosis and Platinum Resistance
- (2010) Kanokwan Iramaneerat et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans
- (2010) Andrew J. Bett et al. VACCINE
- Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4+T-cell-independent CD8+T-cell-mediated tumor control
- (2009) Maria R. Sorensen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4+ T-Cell Responses and Confers Enhanced Protection
- (2009) W. Bayer et al. JOURNAL OF VIROLOGY
- Identification of low-abundance alternatively spliced mRNA variants by exon exclusive reverse transcriptase polymerase chain reaction
- (2008) Feng Wang et al. ANALYTICAL BIOCHEMISTRY
- Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles
- (2008) K. Boller et al. JOURNAL OF GENERAL VIROLOGY
- Human Endogenous Retrovirus K (HML-2) Elements in the Plasma of People with Lymphoma and Breast Cancer
- (2008) R. Contreras-Galindo et al. JOURNAL OF VIROLOGY
- Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
- (2008) M. Li et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started